Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

THYROGEN

THYROTROPIN ALFA

Standard Dose
1.1MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview THYROGEN is listed in Drugs@FDA under application 020898 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient THYROTROPIN ALFA Form and strength INJECTABLE;INJECTION - 1.1MG/VIAL Sponsor GENZYME Submission history Latest submission status date: 2020-03-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview THYROGEN is listed in Drugs@FDA under application 020898 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient THYROTROPIN ALFA Form and strength INJECTABLE;INJECTION - 1.1MG/VIAL Sponsor GENZYME Submission history Latest submission status date: 2020-03-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.